Insulin dysfunction and Tau pathology

Frontiers in Cellular Neuroscience

Volumn 8, Issue FEB, 2014, Pages

  El Khoury, Noura B ^a,b   Gratuze, Maud ^a,b   Papon, Marie Amélie ^b   Bretteville, Alexis ^b   Planel, Emmanuel ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Diabetes mellitus; Kinases; Phosphatases; Tau phosphorylation

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; INSULIN RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN SERINE THREONINE PHOSPHATASE; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOID NEUROPATHY; ANESTHESIA; ARTICLE; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DIABETES MELLITUS; HYPOTHERMIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; NEUROFIBRILLARY TANGLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PAIRED HELICAL FILAMENT; PHOSPHORYLATION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; STRESS; TAUOPATHY; TEMPERATURE; TRANSGENIC MOUSE;

EID: 84894051520     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00022     Document Type: Article

References (249)

1. Alonso, A. C., Zaidi, T., Novak, M., Grundke-Iqbal, I., and Iqbal, K. (2001). Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments / straight filaments. Proc. Natl. Acad. Sci. U.S.A. 98, 6923-6928. doi: 10.1073/pnas.121119298
2. Alonso, A. D., Grundke-Iqbal, I., Barra, H. S., and Iqbal, K.(1997). Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc. Natl. Acad. Sci. U.S.A. 94,298-303. doi: 10.1073/pnas.94.1.298
3. Alonso, A. D. C., Mederlyova, A., Novak, M., Grundke-Iqbal, I., and Iqbal, K. (2004). Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J. Biol. Chem. 279, 34873-34881. doi: 10.1074/jbc.M405131200
4. Andjelkovic, M., Jakubowicz, T., Cron, P., Ming, X. F., Han, J. W., and Hemmings, B. A. (1996). Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 93, 5699-5704. doi: 10.1073/pnas.93.12.5699
5. Arnaud, L., Robakis, N. K., and Figueiredo-Pereira, M. E. (2006). It may take inflammation, phosphorylation and ubiquitination to "tangle" in Alzheimer's disease. Neurodegener. Dis. 3, 313-319. doi: 10.1159/000095638
6. Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., and Hyman, B. T.(1992). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639. doi: 10.1212/WNL.42.3.631
7. Arvanitakis, Z., Schneider, J. A., Wilson, R. S., Li, Y., Arnold, S. E., Wang, Z., et al. (2006). Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 67,1960-1965. doi: 10.1212/01.wnl.0000247053.45483.4e
8. Augustinack, J., Schneider, A., Mandelkow, E.-M., and Hyman, B. T. (2002). Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 103, 26-35. doi: 10.1007/s004010100423
9. Avila, J., Lucas, J. J., Perez, M., and Hernandez, F. (2004). Role of tau protein in both physiological and pathological conditions. Physiol. Rev. 84, 361-384. doi: 10.1152/physrev.00024.2003
10. Banks, W. A., Jaspan, J. B., Huang, W., and Kastin, A. J. (1997a). Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides 18, 1423-1429. doi: 10.1016/S0196-9781(97)00231-3
11. Banks, W. A., Jaspan, J. B., and Kastin, A. J. (1997b). Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides 18, 1257-1262. doi: 10.1016/S0196-9781(97)00198-8
12. Baskin, D. G., Figlewicz, D. P., Woods, S. C., Porte, D. Jr., and Dorsa, D. M. (1987). Insulin in the brain. Annu. Rev. Physiol. 49, 335-347. doi: 10.1146/annurev.ph.49.030187.002003
13. Baskin, D. G., Wilcox, B. J., Figlewicz, D. P., and Dorsa, D. M.(1988). Insulin and insulin-like growth factors in the CNS. Trends Neurosci.11,107-111. doi: 10.1016/0166-2236(88)90155-5
14. Becker, K., Freude, S., Zemva, J., Stohr, O., Krone, W., and Schubert, M. (2012). Chronic peripheral hyperinsulinemia has no substantial influence on tau phosphorylation in vivo. Neurosci. Lett. 516, 306-310. doi: 10.1016/j.neulet.2012.04.022
15. Benedict, C., Brooks, S. J., Kullberg, J., Burgos, J., Kempton, M. J., Nordenskjold, R., et al. (2012). Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly. Diabetes Care 35, 488-494. doi: 10.2337/dc11-2075
16. Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., and Lamb, B. T. (2010). Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68,19-31. doi: 10.1016/j.neuron.2010.08.023
17. Bhat, N. R., and Thirumangalakudi, L. (2013). Increased Tau phosphorylation and impaired brain insulin/IGF signaling in mice fed a high fat/high cholesterol diet. J. Alzheimers Dis. 36, 781-789. doi: 10.3233/JAD-2012- 121030
18. Bierer, L. M., Hof, P. R., Purohit, D. P., Carlin, L., Schmeidler, J., Davis, K. L., et al. (1995). Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch. Neurol. 52, 81-88. doi: 10.1001/arch- neur.1995.00540250089017
19. Biernat, J., Gustke, N., Drewes, G., Mandelkow, E. M., and Mandelkow, E. (1993). Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11,153-163. doi: 10.1016/0896-6273(93)90279-Z
20. Braak, E., Griffing, K., Arai, K., Bohl, J., Bratzke, H., and Braak, H.(1999). Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? Eur. Arch. Psychiatry Clin. Neurosci. 249(Suppl.3),14-22. doi: 10.1007/PL00014168
21. Braak, H., and Braak, E.(1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259. doi: 10.1007/BF00308809
22. Braak, H., and Braak, E. (1997). Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18, 351-357. doi: 10.1016/S0197- 4580(97)00056-0
23. Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., and Lee, V. M.(1993). Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10,1089-1099. doi: 10.1016/0896-6273(93)90057-X
24. Brant, A. M., Jess, T. J., Milligan, G., Brown, C. M., and Gould, G. W.(1993). Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system. Biochem. Biophys. Res. Commun. 192, 1297-1302. doi: 10.1006/bbrc.1993.1557
25. Brazil, D. P., and Hemmings, B. A. (2001). Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26, 657-664. doi: 10.1016/S0968- 0004(01)01958-2
26. Bretteville, A., and Planel, E. (2008). Tau aggregates: toxic, inert, or protective species? J. Alzheimers. Dis. 14, 431-436.
27. Brion, J. P., Passareiro, H., Nunez, J., and Flament-Durand, J. (1985). Mise en evidence immunologique de la proteine tau au niveau des lesions de degeneres- cence neurofibrillaire de la maladie d'Alzheimer. Arch. Biol. (Bruxelles) 95, 229-235.
28. Bruning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., et al. (2000). Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122-2125. doi: 10.1126/science.289.5487.2122
29. Bruning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Horsch, D., Accili, D., et al. (1998). A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell2, 559-569. doi: 10.1016/S1097-2765(00)80155-0
30. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A., and Hof, P. R. (2000). Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33, 95-130. doi: 10.1016/S0165-0173(00)00019-9
31. Burnouf, S., Martire, A., Derisbourg, M., Laurent, C., Belarbi, K., Leboucher, A., et al. (2013). NMDA receptor dysfunction contributes to impaired brain- derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model. Aging Cell 12,11-23. doi: 10.1111/acel.12018
32. Bussiere, T., Hof, P. R., Mailliot, C., Brown, C. D., Caillet-Boudin, M. L., Perl, D. P., et al. (1999). Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration. Acta Neuropathol. (Berl.) 97, 221-230. doi: 10.1007/s004010050978
33. Butner, K. A., and Kirschner, M. W. (1991). Tau protein binds to microtubules through a flexible array of distributed weak sites. J. Cell Biol. 115, 717-730. doi: 10.1083/jcb.115.3.717
34. CDC. (2008). National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
35. Chen, J., Kanai, Y., Cowan, N. J., and Hirokawa, N.(1992). Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons. Nature 360, 674-677. doi: 10.1038/360674a0
36. Chen, S., Liu, A. R., An, F. M., Yao, W. B., and Gao, X. D. (2011). Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4. Age (Dordr). 34,1211-1224. doi: 10.1007/s11357-011-9303-8
37. Chen, Y., Liang, Z., Blanchard, J., Dai, C. L., Sun, S., Lee, M. H., et al. (2013a). A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse). Mol. Neurobiol. 47, 711-725. doi: 10.1007/s12035-012-8375-5
38. Chen, Y., Liang, Z., Tian, Z., Blanchard, J., Dai, C. L., Chalbot, S., et al. (2013b). Intracerebroventricular Streptozotocin Exacerbates Alzheimer-Like Changes of 3xTg-AD Mice. Mol. Neurobiol. doi: 10.1007/s12035-013- 8539-y. [Epub ahead of print].
39. Chu, W. Z., and Qian, C. Y. (2005). Expressions ofAbeta1-40, Abeta1-42, tau202, tau396 and tau404 after intracerebroventricular injection of streptozotocin in rats. Di Yi Jun. Yi Da Xue Xue Bao 25,168-170, 173.
40. Cleveland, D. W., Hwo, S. Y., and Kirschner, M. W.(1977a). Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J. Mol. Biol. 116, 227-247. doi: 10.1016/0022-2836(77)90214-5
41. Cleveland, D. W., Hwo, S. Y., and Kirschner, M. W.(1977b). Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J. Mol. Biol. 116,207-225. doi: 10.1016/0022-2836(77)90213-3
42. Clodfelder-Miller, B., De Sarno, P., Zmijewska, A. A., Song, L., and Jope, R. S. (2005). Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3. J. Biol. Chem. 280, 39723-39731. doi: 10.1074/jbc.M508824200
43. Clodfelder-Miller, B. J., Zmijewska, A. A., Johnson, G. V., and Jope, R. S. (2006). Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes 55, 3320-3325. doi: 10.2337/db06-0485
44. Coleman, D. L. (1978). Obese and diabetes: two mutant genes causing diabetes- obesity syndromes in mice. Diabetologia 14,141-148. doi: 10.1007/BF00429772
45. Craft, S., Baker, L. D., Montine, T. J., Minoshima, S., Watson, G. S., Claxton, A., et al. (2012). Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch. Neurol. 69, 29-38. doi: 10.1001/archneurol.2011.233
46. Craft, S., and Watson, G. S. (2004). Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. 3,169-178. doi: 10.1016/S1474-4422(04)00681-7
47. Crane, P. K., Walker, R., Hubbard, R. A., Li, G., Nathan, D. M., Zheng, H., et al. (2013a). Glucose levels and risk of dementia. N. Engl. J. Med. 369, 540-548. doi: 10.1056/NEJMoa1215740
48. Crane, P. K., Walker, R., and Larson, E. B. (2013b). Glucose levels and risk of dementia. N. Engl. J. Med. 369, 1863-1864. doi: 10.1056/NEJMoa1215740
49. Cryer, P. E.(1997). Hypoglycemia: Pathophysiology, Diagnosis, and Treatment. New York, NY: Oxford University Press.
50. Cryer, P. E. (2001). Hypoglycemia risk reduction in type 1 diabetes. Exp. Clin. Endocrinol. Diabetes 109(Suppl.2), S412-S423. doi: 10.1055/s-2001-18599
51. Cryer, P. E. (2004). Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N. Engl. J. Med. 350, 2272-2279. doi: 10.1056/NEJMra031354
52. Cryer, P. E., Davis, S. N., and Shamoon, H. (2003). Hypoglycemia in diabetes. Diabetes Care 26, 1902-1912. doi: 10.2337/diacare.26.6.1902
53. Dahlquist, G., and Kallen, B. (2007). School performance in children with type 1 diabetes-a population-based register study. Diabetologia 50, 957-964. doi: 10.1007/s00125-007-0615-2
54. Dandona, P. (2002). Endothelium, inflammation, and diabetes. Curr. Diab. Rep. 2, 311-315. doi: 10.1007/s11892-002-0019-0
55. De Felice, F. G. (2013). Alzheimer's disease and insulin resistance: translating basic science into clinical applications. J. Clin. Invest. 123, 531-539. doi: 10.1172/JCI64595
56. Defronzo, R. A. (2004). Pathogenesis of type 2 diabetes mellitus. Med. Clin. North Am. 88, 787-835. doi: 10.1016/j.mcna.2004.04.013
57. Delacourte, A., and Buee, L. (2000). Tau pathology: a marker of neurodegenerative disorders. Curr. Opin. Neurol.13, 371-376. doi: 10.1097/00019052-20000800000002
58. Delacourte, A., David, J. P., Sergeant, N., Buee, L., Wattez, A., Vermersch, P., et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52,1158-1165. doi: 10.1212/WNL.52.6.1158
59. Delacourte, A., Sergeant, N., Wattez, A., Maurage, C. A., Lebert, F., Pasquier, F., et al. (2002). Tau aggregation in the hippocampal formation: an ageing or a pathological process? Exp. Gerontol. 37,1291-1296. doi: 10.1016/S0531- 5565(02)00141-9
60. Delaere, P., Duyckaerts, C., Brion, J. P., Poulain, V., and Hauw, J. J. (1989). Tau, paired helical filaments and amyloid in the neocortex: a morphome- tric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type. Acta Neuropathol. (Berl.) 77, 645-653. doi: 10.1007/BF00687893
61. De La Monte, S. M., Longato, L., Tong, M., and Wands, J. R. (2009). Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. Curr. Opin. Investig. Drugs 10, 1049-1060.
62. De La Monte, S. M., Tong, M., Lester-Coll, N., Plater, M. Jr., and Wands, J. R. (2006). Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J. Alzheimers. Dis.10, 89-109.
63. Delaney, C. A., Dunger, A., Di Matteo, M., Cunningham, J. M., Green, M. H., and Green, I. C. (1995). Comparison of inhibition of glucose-stimulated insulin secretion in rat islets of Langerhans by streptozotocin and methyl and ethyl nitrosoureas and methanesulphonates. Lack of correlation with nitric oxide- releasing or O6-alkylating ability. Biochem. Pharmacol. 50, 2015-2020. doi: 10.1016/0006-2952(95)02102-7
64. Deng, Y., Li, B., Liu, Y., Iqbal, K., Grundke-Iqbal, I., and Gong, C. X. (2009). Dysregulation of insulin signaling, glucose transporters, O- GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease. Am. J. Pathol. 175, 2089-2098. doi: 10.2353/ajpath.2009.090157
65. Deters, N., Ittner, L. M., and Gotz, J. (2009). Substrate-specific reduction of PP2A activity exaggerates tau pathology. Biochem. Biophys. Res. Commun. 379, 400-405. doi: 10.1016/j.bbrc.2008.12.140
66. Devaskar, S. U., Giddings, S. J., Rajakumar, P. A., Carnaghi, L. R., Menon, R. K., and Zahm, D. S. (1994). Insulin gene expression and insulin synthesis in mammalian neuronal cells. J. Biol. Chem. 269, 8445-8454.
67. Drewes, G., Trinczek, B., Illenberger, S., Biernat, J., Schmitt-Ulms, G., Meyer, H. E., et al. (1995). Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262. J. Biol. Chem. 270, 7679-7688.
68. Du, L. L., Xie, J. Z., Cheng, X. S., Li, X. H., Kong, F. L., Jiang, X., et al. (2013). Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin- induced tau hyperphosphorylation and cognitive injuries in rat hippocampi. Age (Dordr). doi: 10.1007/s11357-013-9592-1. [Epub ahead of print].
69. Duarte, A. I., Moreira, P. I., and Oliveira, C. R. (2012). Insulin in central nervous system: more than just a peripheral hormone. J. Aging Res. 2012:384017. doi: 10.1155/2012/384017
70. Duelli, R., Schrock, H., Kuschinsky, W., and Hoyer, S. (1994). Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int. J. Dev. Neurosci.12, 737-743. doi: 10.1016/0736-5748(94)90053-1
71. Duvillie, B., Cordonnier, N., Deltour, L., Dandoy-Dron, F., Itier, J. M., Monthioux, E., et al. (1997). Phenotypic alterations in insulin-deficient mutant mice. Proc. Natl. Acad. Sci. U.S.A. 94, 5137-5140. doi: 10.1073/pnas.94.10.5137
72. Duyckaerts, C., Bennecib, M., Grignon, Y., Uchihara, T., He, Y., Piette, F., et al. (1997). Modeling the relation between neurofibrillary tangles and intellectual status. Neurobiol. Aging 18, 267-273. doi: 10.1016/S0197-4580(97)80306-5
73. Duyckaerts, C., Colle, M. A., Dessi, F., Piette, F., and Hauw, J. J. (1998). Progression of Alzheimer histopathological changes. Acta Neurol. Belg. 98,180-185.
74. Ellis, E. A., Grant, M. B., Murray, F. T., Wachowski, M. B., Guberski, D. L., Kubilis, P. S., et al. (1998). Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic. Biol. Med. 24,111-120. doi: 10.1016/S0891- 5849(97)00202-5
75. Escribano, L., Simon, A. M., Gimeno, E., Cuadrado-Tejedor, M., Lopez De Maturana, R., Garcia-Osta, A., et al. (2010). Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology 35, 1593-1604. doi: 10.1038/npp.2010.32
76. Festa, A., Williams, K., D'agostino, R. Jr., Wagenknecht, L. E., and Haffner, S. M. (2006). The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 55, 1114-1120. doi: 10.2337/diabetes.55.04.06.db05-1100
77. Fox, M. A., Chen, R. S., and Holmes, C. S. (2003). Gender differences in memory and learning in children with insulin-dependent diabetes mellitus (IDDM) over a 4-year follow-up interval. J. Pediatr. Psychol. 28, 569-578. doi: 10.1093/jpepsy/jsg047
78. Freiherr, J., Hallschmid, M., Frey, W. H., 2nd, Brunner, Y. F., Chapman, C. D., Holscher, C., et al. (2013). Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence. CNS Drugs 27, 505-514. doi: 10.1007/s40263-013-0076-8
79. Frolich, L., Blum-Degen, D., Riederer, P., and Hoyer, S. (1999). A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann. N. Y. Acad. Sci. 893,290-293. doi: 10.1111/j.1749-6632.1999.tb07839.x
80. Ganda, O. P., Rossini, A. A., and Like, A. A. (1976). Studies on streptozotocin diabetes. Diabetes 25, 595-603. doi: 10.2337/diab.25.7.595
81. Gasparini, L., Netzer, W. J., Greengard, P., and Xu, H. (2002). Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol. Sci. 23, 288-293. doi: 10.1016/S0165-6147(02)02037-0
82. Gerozissis, K. (2008). Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies. Eur. J. Pharmacol. 585, 38-49. doi: 10.1016/j.ejphar.2008.01.050
83. Giannakopoulos, P., Herrmann, F. R., Bussiere, T., Bouras, C., Kovari, E., Perl, D. P., et al. (2003). Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60, 1495-1500. doi: 10.1212/01.WNL.0000063311.58879.01
84. Glenner, G. G., and Wong, C. W. (1984). Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890. doi: 10.1016/S0006- 291X(84)80190-4
85. Goedert, M., Jakes, R., Crowther, R. A., Cohen, P., Vanmechelen, E., Vandermeeren, M., et al. (1994). Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem. J. 301, 871-877.
86. Goedert, M., Jakes, R., Crowther, R. A., Six, J., Lubke, U., Vandermeeren, M., et al. (1993). The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc. Natl. Acad. Sci. U.S.A 90, 5066-5070. doi: 10.1073/pnas.90.11.5066
87. Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., and Crowther, R. A. (1989). Cloning and sequencing of the cDNA encoding an isoform of microtubule- associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8, 393-399.
88. Gomez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R., et al. (1997). Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41,17-24. doi: 10.1002/ana. 410410106
89. Gong, C. X., Grundke-Iqbal, I., and Iqbal, K. (1994). Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience 61,765-772. doi: 10.1016/0306-4522(94)90400-6
90. Gong, C. X., and Iqbal, K. (2008). Hyperphosphorylation of microtubule- associated protein tau: a promising therapeutic target for Alzheimer disease. Curr. Med. Chem.15, 2321-2328. doi: 10.2174/092986708785909111
91. Gong, C. X., Lidsky, T., Wegiel, J., Zuck, L., Grundke-Iqbal, I., and Iqbal, K. (2000). Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J. Biol. Chem. 275, 5535-5544. doi: 10.1074/jbc.275.8.5535
92. Gong, C. X., Shaikh, S., Wang, J. Z., Zaidi, T., Grundke-Iqbal, I., and Iqbal, K. (1995).Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J. Neurochem. 65, 732-738. doi: 10.1046/j.1471- 4159.1995.65020732.x
93. Gong, C. X., Singh, T. J., Grundke-Iqbal, I., and Iqbal, K. (1993). Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 61, 921-927. doi: 10.1111/j.1471-4159.1993.tb03603.x
94. Goodner, C. J., and Berrie, M. A. (1977). The failure of rat hypothalamic tissues to take up labeled insulin in vivo or to respond to insulin in vitro. Endocrinology 101, 605-612. doi: 10.1210/endo-101-2-605
95. Gotz, J., Chen, F., Barmettler, R., and Nitsch, R. M. (2001). Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem. 276, 529-534. doi: 10.1074/jbc.M006531200
96. Grunblatt, E., Salkovic-Petrisic, M., Osmanovic, J., Riederer, P., and Hoyer, S. (2007). Brain insulin system dysfunction in streptozotocin intrac- erebroventricularly treated rats generates hyperphosphorylated tau protein. J. Neurochem. 101, 757-770. doi: 10.1111/j.1471-4159.2006. 04368.x
97. Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., and Wisniewski, H. M. (1986). Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261, 6084-6089.
98. Guillozet, A. L., Weintraub, S., Mash, D. C., and Mesulam, M. M. (2003). Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch. Neurol. 60, 729-736. doi: 10.1001/archneur.60.5.729
99. Gustke, N., Trinczek, B., Biernat, J., Mandelkow, E. M., and Mandelkow, E.(1994). Domains of tau protein and interactions with microtubules. Biochemistry 33, 9511-9522. doi: 10.1021/bi00198a017
100. Hak, A. E., Pols, H. A., Stehouwer, C. D., Meijer, J., Kiliaan, A. J., Hofman, A., et al. (2001). Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J. Clin. Endocrinol. Metab. 86, 4398-4405. doi: 10.1210/jc.86.9.4398
101. Han, W. N., Holscher, C., Yuan, L., Yang, W., Wang, X. H., Wu, M. N., et al. (2013). Liraglutide protects against amyloid-beta protein-induced impairment of spatial learning and memory in rats. Neurobiol. Aging 34, 576-588. doi: 10.1016/j.neurobiolaging.2012.04.009
102. Hardy, J. A., and Higgins, G. A. (1992). Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185. doi: 10.1126/science.1566067
103. Harman, D. (2002). Alzheimer's disease: role of aging in pathogenesis. Ann. N.Y. Acad. Sci. 959, 384-395; discussion 463-385. doi: 10.1111/j.1749- 6632.2002.tb02109.x
104. Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., et al. (1998). Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U.S.A. 95,10896-10901. doi: 10.1073/pnas.95.18.10896
105. Hasegawa, M., Jakes, R., Crowther, R. A., Lee, V. M., Ihara, Y., and Goedert, M. (1996).Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein. FEBS Lett. 384, 25-30. doi: 10.1016/0014-5793(96)00271-2
106. Havrankova, J., Roth, J., and Brownstein, M.(1978a). Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272, 827-829. doi: 10.1038/272827a0
107. Havrankova, J., Schmechel, D., Roth, J., and Brownstein, M. (1978b). Identification of insulin in rat brain. Proc. Natl. Acad. Sci. U.S.A. 75, 5737-5741. doi: 10.1073/pnas.75.11.5737
108. Heidenreich, K. A., and Gilmore, P. R. (1985). Structural and functional characteristics of insulin receptors in rat neuroblastoma cells. J. Neurochem. 45, 1642-1648. doi: 10.1111/j.1471-4159.1985.tb07237.x
109. Heidenreich, K. A., Zahniser, N. R., Berhanu, P., Brandenburg, D., and Olefsky, J. M. (1983). Structural differences between insulin receptors in the brain and peripheral target tissues. J. Biol. Chem. 258, 8527-8530.
110. Hernandez, F., Lucas, J. J., and Avila, J. (2013). GSK3 and tau: two convergence points in Alzheimer's disease. J. Alzheimers. Dis. 33(Suppl.1),S141-S144. doi: 10.3233/JAD-2012-129025
111. Himmler, A., Drechsel, D., Kirschner, M. W., and Martin, D. W. Jr. (1989). Tau consists of a set of proteins with repeated C-terminal microtubule- binding domains and variable N-terminal domains. Mol. Cell. Biol. 9, 1381-1388.
112. Hong, M., and Lee, V. M.(1997). Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J. Biol. Chem. 272, 19547-19553. doi: 10.1074/jbc.272.31.19547
113. Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., et al. (2010). Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68, 1067-1081. doi: 10.1016/j.neuron.2010.11.030
114. Hoyer, S. (1998). Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J. Neural. Transm. 105, 415-422. doi: 10.1007/s007020050067
115. Hu, S. H., Jiang, T., Yang, S. S., and Yang, Y. (2013). Pioglitazone ameliorates intracerebral insulin resistance and tau-protein hyperphosphorylation in rats with type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 121, 220-224. doi: 10.1055/s- 0032-1333277
116. Hummel, K. P., Dickie, M. M., and Coleman, D. L. (1966). Diabetes, a new mutation in the mouse. Science 153, 1127-1128. doi: 10.1126/science.153.3740.1127
117. IDF. (2013). IDF Diabetes Atlas, 6th Edn. Brussels: International Diabetes Federation.
118. Ishrat, T., Khan, M. B., Hoda, M. N., Yousuf, S., Ahmad, M., Ansari, M. A., et al. (2006). Coenzyme Q10 modulates cognitive impairment against intrac- erebroventricular injection of streptozotocin in rats. Behav. Brain Res. 171, 9-16. doi: 10.1016/j.bbr.2006.03.009
119. Jolivalt, C. G., Hurford, R., Lee, C. A., Dumaop, W., Rockenstein, E., and Masliah, E. (2010). Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Exp. Neurol. 223, 422-431. doi: 10.1016/j.expneurol.2009.11.005
120. Jolivalt, C. G., Lee, C. A., Beiswenger, K. K., Smith, J. L., Orlov, M., Torrance, M. A., et al. (2008). Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin. J. Neurosci. Res. 86, 3265-3274. doi: 10.1002/jnr.21787
121. Julien, C., Tremblay, C., Phivilay, A., Berthiaume, L., Emond, V., Julien, P., et al. (2010). High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiol. Aging 31,1516-1531. doi: 10.1016/j.neurobiolaging.2008.08.022
122. Jung, H. J., Kim, Y. J., Eggert, S., Chung, K. C., Choi, K. S., and Park, S. A. (2013). Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62. Exp. Neurol. 248, 441-450. doi: 10.1016/j.expneurol.2013.07.013
123. Jung, H. J., Park, S. S., Mok, J. O., Lee, T. K., Park, C. S., and Park, S. A. (2011). Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes. Exp. Neurol. 228, 232-241. doi: 10.1016/j.expneurol.2011.01.012
124. Ke, Y. D., Delerue, F., Gladbach, A., Gotz, J., and Ittner, L. M. (2009). Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease. PLoS ONE 4:e7917. doi: 10.1371/journal.pone.0007917
125. Kilgour, R. D., and Williams, P. A. (1996). Effects of diabetes and food deprivation on shivering activity during progressive hypothermia in the rat. Comp. Biochem. Physiol. A Physiol. 114, 159-165. doi: 10.1016/0300-9629(95)02108-6
126. Kilgour, R. D., and Williams, P. A. (1998). Diabetes affects blood pressure and heart rate responses during acute hypothermia. Acta Physiol. Scand. 162, 27-32. doi: 10.1046/j.1365-201X.1998.0283f.x
127. Kim, B., Backus, C., Oh, S., Hayes, J. M., and Feldman, E. L. (2009). Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 150, 5294-5301. doi: 10.1210/en.2009-0695
128. Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., and Laferla, M. (2005). Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J. Neurosci. 25, 8843-8853. doi: 10.1523/JNEUROSCI.2868-05.2005
129. Krogh-Madsen, R., Plomgaard, P., Keller, P., Keller, C., and Pedersen, B. K. (2004). Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue. Am. J. Physiol. Endocrinol. Metab. 286, E234-E238. doi: 10.1152/ajpendo.00274.2003
130. Ksiezak-Reding, H., Pyo, H. K., Feinstein, B., and Pasinetti, G. M. (2003). Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro. Biochim. Biophys. Acta 1639, 159-168. doi: 10.1016/j.bbadis.2003.09.001
131. Kulkarni, R. N., Bruning, J. C., Winnay, J. N., Postic, C., Magnuson, M. A., and Kahn, C. R.(1999). Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96, 329-339. doi: 10.1016/S0092-8674(00)80546-2
132. Labouebe, G., Liu, S., Dias, C., Zou, H., Wong, J. C., Karunakaran, S., et al. (2013). Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids. Nat. Neurosci.16, 300-308. doi: 10.1038/nn.3321
133. Laferla, F. M., Green, K. N., and Oddo, S. (2007). Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 8, 499-509. doi: 10.1038/nrn2168
134. Lamberts, S. W., Van Den Beld, A. W., and Van Der Lely, A. J. (1997). The endocrinology of aging. Science 278, 419-424. doi: 10.1126/sci- ence.278.5337.419
135. Lannert, H., and Hoyer, S. (1998). Intracerebroventricular administration of strep- tozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav. Neurosci. 112, 1199-1208. doi: 10.1037/0735-7044.112.5.1199
136. Leboucher, A., Laurent, C., Fernandez-Gomez, F. J., Burnouf, S., Troquier, L., Eddarkaoui, S., et al. (2012). Detrimental effects of diet-induced obesity on tau pathology is independent of insulin resistance in tau transgenic mice. Diabetes 65,1681-1688. doi: 10.2337/db12-0866
137. Le Freche, H., Brouillette, J., Fernandez-Gomez, F. J., Patin, P., Caillierez, R., Zommer, N., et al. (2012). Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment. Anesthesiology 116, 779-787. doi: 10.1097/ALN.0b013e31824be8c7
138. Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'brien, P. C., et al. (1997). Risk of dementia among persons with diabetes melli- tus: a population-based cohort study. Am. J. Epidemiol. 145, 301-308. doi: 10.1093/oxfordjournals.aje.a009106
139. Leiter, E. H. (2001). The NOD mouse: a model for insulin-dependent diabetes mellitus. Curr Protoc Immunol. Chapter 15, Unit 15.9. doi: 10.1002/0471142735.im1509s24
140. Leloup, C., Arluison, M., Lepetit, N., Cartier, N., Marfaing-Jallat, P., Ferre, P., et al. (1994). Glucose transporter 2 (GLUT 2): expression in specific brain nuclei. Brain Res. 638, 221-226. doi: 10.1016/0006-8993(94)90653-X
141. Le Roith, D., and Zick, Y. (2001). Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 24, 588-597. doi: 10.2337/diacare.24.3.588
142. Lerorrtt, D., Rojeski, M., and Roth, J. (1988). Insulin receptors in brain and other tissues: similarities and differences. Neurochem. Int. 12, 419-423. doi: 10.1016/0197-0186(88)90023-X
143. Lesort, M., and Johnson, G. V. (2000). Insulin-like growth factor-1 and insulin mediate transient site- selective increases in tau phosphorylation in pri- marycortical neurons. Neuroscience 99, 305-316. doi: 10.1016/S0306-4522(00) 00200-1
144. Lesort, M., Jope, R. S., and Johnson, G. V. (1999). Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J. Neurochem. 72, 576-584. doi: 10.1046/j.1471- 4159.1999.0720576.x
145. Lester-Coll, N., Rivera, E. J., Soscia, S. J., Doiron, K., Wands, J. R., and De La Monte, S. M. (2006). Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J. Alzheimers. Dis. 9, 13-33.
146. Lewis, J., Dickson, D. W., Lin, W. L., Chisholm, L., Corral, A., Jones, G., et al. (2001). Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487-1491. doi: 10.1126/science.1058189
147. Li, J., Deng, J., Sheng, W., and Zuo, Z. (2012a). Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice. Pharmacol. Biochem. Behav. 101, 564-574. doi: 10.1016/j.pbb.2012.03.002
148. Li, L., Zhang, Z. F., Holscher, C., Gao, C., Jiang, Y. H., and Liu, Y. Z. (2012b). (Val(8)) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains. Eur. J. Pharmacol. 674, 280-286. doi: 10.1016/j.ejphar.2011.11.005
149. Li, Y., Liu, L., Barger, S. W., and Griffin, W. S. (2003). Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J. Neurosci. 23, 1605-1611.
150. Li, Z. G., Zhang, W., and Sima, A. A. (2007). Alzheimer-like changes in rat models ofspontaneous diabetes. Diabetes 56, 1817-1824. doi: 10.2337/db07-0171
151. Lien, E., Means, T. K., Heine, H., Yoshimura, A., Kusumoto, S., Fukase, K., et al. (2000). Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105, 497-504. doi: 10.1172/JCI8541
152. Liu, F., Grundke-Iqbal, I., Iqbal, K., and Gong, C. X. (2005). Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 22, 1942-1950. doi: 10.1111/j.1460-9568.2005.04391.x
153. Luchsinger, J. A., Tang, M. X., Shea, S., and Mayeux, R. (2004). Hyperinsulinemia and risk of Alzheimer disease. Neurology 63,1187-1192. doi: 10.1212/01.WNL.0000140292.04932.87
154. Luchsinger, J. A., Tang, M. X., Stern, Y., Shea, S., and Mayeux, R. (2001). Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am. J. Epidemiol. 154, 635-641. doi: 10.1093/aje/154.7.635
155. Lue, L. F., Kuo, Y. M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., et al. (1999). Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853-862. doi: 10.1016/S0002- 9440(10)65184-X
156. Makino, S., Kunimoto, K., Muraoka, Y., Mizushima, Y., Katagiri, K., and Tochino, Y. (1980). Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29, 1-13.
157. Marks, J. L., and Eastman, C. J. (1990). Ontogeny of insulin binding in different regions of the rat brain. Dev. Neurosci.12, 349-358. doi: 10.1159/000111863
158. Marks, J. L., King, M. G., and Baskin, D. G. (1991). Localization of insulin and type 1 IGF receptors in rat brain by in vitro autoradiography and in situ hybridization. Adv. Exp. Med. Biol. 293, 459-470. doi: 10.1007/978-1-46845949-4-41
159. Matsuo, E. S., Shin, R. W., Billingsley, M. L., Van Devoorde, A., O'connor, M., Trojanowski, J. Q., et al. (1994). Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13, 989-1002. doi: 10.1016/0896-6273(94) 90264-X
160. McCrimmon, R. J., and Sherwin, R. S. (2010). Hypoglycemia in type 1 diabetes. Diabetes 59, 2333-2339. doi: 10.2337/db10-0103
161. Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., et al. (2000). Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6, 87-97. doi: 10.1016/S1097-2765(00)00010-1
162. Moroz, N., Tong, M., Longato, L., Xu, H., and De La Monte, S. M. (2008). Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J. Alzheimers. Dis. 15, 29-44.
163. Naik, R. G., and Palmer, J. P. (2007). "Latent autoimmune diabetes in adults" in Diabetes in Adults: Principles and Practice, eds S. Jabbour and E. A. Stephens (London, GBR: Taylor & Francis), 288.
164. Neil, H. A., Dawson, J. A., and Baker, J. E. (1986). Risk of hypothermia in elderly patients with diabetes. Br. Med. J. (Clin. Res. Ed). 293, 416-418. doi: 10.1136/bmj.293.6544.416
165. Ngarmukos, C., Baur, E. L., and Kumagai, A. K. (2001). Co-localization of GLUT1 and GLUT4 in the blood-brain barrier of the rat ventromedial hypothalamus. Brain Res. 900, 1-8. doi: 10.1016/S0006-8993(01)02184-9
166. Nistico, R., Cavallucci, V., Piccinin, S., Macri, S., Pignatelli, M., Mehdawy, B., et al. (2012). Insulin receptor beta-subunit haploinsufficiency impairs hippocampal late-phase LTP and recognition memory. Neuromolecular Med. 14, 262-269. doi: 10.1007/s12017-012-8184-z
167. Nitsch, R., and Hoyer, S. (1991). Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci. Lett. 128, 199-202. doi: 10.1016/0304-3940(91)90260-Z
168. Northam, E. A., Anderson, P. J., Jacobs, R., Hughes, M., Warne, G. L., and Werther, G. A. (2001). Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 24, 1541-1546. doi: 10.2337/diacare.24.9.1541
169. Ott, A., Stolk, R. P., Van Harskamp, F., Pols, H. A., Hofman, A., and Breteler, M. M.(1999). Diabetes mellitus and the risk of dementia: the Rotterdam study [see comments]. Neurology 53, 1937-1942. doi: 10.1212/WNL.53.9.1937
170. Palop, J. J., Chin, J., and Mucke, L. (2006). A network dysfunction perspective on neurodegenerative diseases. Nature 443, 768-773. doi: 10.1038/ nature05289
171. Papon, M. A., El Khoury, N. B., Marcouiller, F., Julien, C., Morin, F., Bretteville, A., et al. (2013). Deregulation of protein phosphatase 2A and hyperphosphorylation of tau protein following onset of diabetes in NOD mice. Diabetes 62, 609-617. doi: 10.2337/db12-0187
172. Papon, M. A., Whittington, R. A., El-Khoury, N. B., and Planel, E. (2011). Alzheimer's disease and anesthesia. Front. Neurosci. 4:272. doi: 10.3389/fnins.2010.00272
173. Pathan, A. R., Viswanad, B., Sonkusare, S. K., and Ramarao, P. (2006). Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci. 79, 2209-2216. doi: 10.1016/j.lfs.2006.07.018
174. Perez, M., Ribe, E., Rubio, A., Lim, F., Moran, M. A., Ramos, P. G., et al. (2005). Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation. Neuroscience 130, 339-347. doi: 10.1016/j.neuroscience.2004.09.029
175. Pirola, L., Johnston, A. M., and Van Obberghen, E. (2004). Modulation of insulin action. Diabetologia 47,170-184. doi: 10.1007/s00125-003-1313-3
176. Pistell, P. J., Morrison, C. D., Gupta, S., Knight, A. G., Keller, J. N., Ingram, D. K., et al. (2010). Cognitive impairment following high fat diet consumption is associated with brain inflammation. J. Neuroimmunol. 219, 25-32. doi: 10.1016/j.jneuroim.2009.11.010
177. Planel, E., Miyasaka, T., Launey, T., Chui, D. H., Tanemura, K., Sato, S., et al. (2004). Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J. Neurosci. 24, 2401-2411. doi: 10.1523/JNEUROSCI.5561-03.2004
178. Planel, E., Richter, K. E., Nolan, C. E., Finley, J. E., Liu, L., Wen, Y., et al. (2007a). Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J. Neurosci. 27, 3090-3097. doi: 10.1523/JNEUROSCI.4854-06.2007
179. Planel, E., Tatebayashi, Y., Miyasaka, T., Liu, L., Wang, L., Herman, M., et al. (2007b). Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J. Neurosci. 27, 13635-13648. doi: 10.1523/JNEUROSCI.3949-07.2007
180. Planel, E., Sun, X., and Takashima, A. (2002). Role of GSK-3 beta in Alzheimer's disease pathology. Drug Dev. Res. 56, 491-510. doi: 10.1002/ ddr.10100
181. Planel, E., Yasutake, K., Fujita, S. C., and Ishiguro, K. (2001). Inhibition of protein phosphatase 2A overrides Tau protein kinase I / glycogen synthase kinase 3beta and Cyclin-dependant kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J. Biol. Chem. 276, 34298-34306. doi: 10.1074/jbc.M102780200
182. Plaschke, K., Kopitz, J., Siegelin, M., Schliebs, R., Salkovic-Petrisic, M., Riederer, P., et al. (2010). Insulin-resistant brain state after intracerebroventricular strep- tozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP- overexpressing mice. J. Alzheimers. Dis.19, 691-704. doi: 10.3233/JAD-2010- 1270
183. Polydoro, M., Acker, C. M., Duff, K., Castillo, P. E., and Davies, P. (2009). Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. J. Neurosci. 29, 10741-10749. doi: 10.1523/JNEUROSCI.1065-09.2009
184. Prickaerts, J., De Vente, J., Honig, W., Steinbusch, H., Ittersum, M. M. V., Blokland, A., et al. (2000). Nitric oxide synthase does not mediate neurotoxicity after an i.c.v. injection of streptozotocin in the rat. J. Neural. Transm. 107, 745-766. doi: 10.1007/s007020070056
185. Prickaerts, J., Fahrig, T., and Blokland, A. (1999). Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis. Behav. Brain Res. 102, 73-88. doi: 10.1016/S0166-4328(98)00158-2
186. Qu, Z., Jiao, Z., Sun, X., Zhao, Y., Ren, J., and Xu, G. (2011). Effects of streptozotocin-induced diabetes on tau phosphorylation in the rat brain. Brain Res. 1383, 300-306. doi: 10.1016/j.brainres.2011.01.084
187. Querfurth, H. W., and Laferla, F. M. (2010). Alzheimer's disease. N. Engl. J. Med. 362, 329-344. doi: 10.1056/NEJMra0909142
188. Quintanilla, R. A., Orellana, D. I., Gonzalez-Billault, C., and Maccioni, R. B. (2004). Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp. Cell Res. 295, 245-257. doi: 10.1016/j.yexcr.2004.01.002
189. Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., and Ferreira, A. (2002). Tau is essential to beta -amyloid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 99, 6364-6369. doi: 10.1073/pnas.092136199
190. Reger, M. A., Watson, G. S., Green, P. S., Baker, L. D., Cholerton, B., Fishel, M. A., et al. (2008a). Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J. Alzheimers. Dis.13, 323-331.
191. Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L., Cholerton, B., et al. (2008b). Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 70, 440-448. doi: 10.1212/01.WNL.0000265401.62434.36
192. Ribe, E. M., Perez, M., Puig, B., Gich, I., Lim, F., Cuadrado, M., et al. (2005). Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. Neurobiol. Dis. 20, 814-822. doi: 10.1016/j.nbd.2005.05.027
193. Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., et al. (2007). Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754. doi: 10.1126/science.1141736
194. Ronnemaa, E., Zethelius, B., Sundelof, J., Sundstrom, J., Degerman- Gunnarsson, M., Berne, C., et al. (2008). Impaired insulin secretion increases the risk of Alzheimer disease. Neurology 71, 1065-1071. doi: 10.1212/01.wnl.0000310646.32212.3a
195. Roriz-Filho, J. S., Sa-Roriz, T. M., Rosset, I., Camozzato, A. L., Santos, A. C., Chaves, M. L., et al. (2009). (Pre)diabetes, brain aging, and cognition. Biochim. Biophys. Acta. 1792,432-443. doi: 10.1016/j.bbadis.2008.12.003
196. Saez, T. E., Pehar, M., Vargas, M., Barbeito, L., and Maccioni, R. B. (2004). Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons. In Vivo 18, 275-280.
197. Salkovic-Petrisic, M., and Hoyer, S. (2007). Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J. Neural Transm. Suppl. 72, 217-233.
198. Salkovic-Petrisic, M., Tribl, F., Schmidt, M., Hoyer, S., and Riederer, P. (2006). Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J. Neurochem. 96, 1005-1015. doi: 10.1111/j.1471-4159.2005.03637.x
199. Saravia, F. E., Revsin, Y., Gonzalez Deniselle, M. C., Gonzalez, S. L., Roig, P., Lima, A., et al. (2002). Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin- treated mice. Brain Res. 957, 345-353. doi: 10.1016/S0006-8993(02)03675-2
200. Sato, S., Tatebayashi, Y., Akagi, T., Chui, D. H., Murayama, M., Miyasaka, T., et al. (2002). Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells. J. Biol. Chem. 277, 42060-42065. doi: 10.1074/jbc.M202241200
201. Schechter, R., Beju, D., and Miller, K. E. (2005). The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse. Biochem. Biophys. Res. Commun. 334, 979-986. doi: 10.1016/j.bbrc.2005.07.001
202. Schechter, R., Holtzclaw, L., Sadiq, F., Kahn, A., and Devaskar, S. (1988). Insulin synthesis by isolated rabbit neurons. Endocrinology 123, 505-513. doi: 10.1210/endo-123-1-505
203. Schechter, R., Sadiq, H. F., and Devaskar, S. U.(1990). Insulin and insulin mRNA are detected in neuronal cell cultures maintained in an insulin-free/serum-free medium. J. Histochem. Cytochem. 38, 829-836. doi: 10.1177/38.6.2186089
204. Schoenle, E. J., Schoenle, D., Molinari, L., and Largo, R. H. (2002). Impaired intellectual development in children with Type I diabetes: association with HbA(1c), age at diagnosis and sex. Diabetologia 45,108-114. doi: 10.1007/s125-002- 8250-6
205. Schubert, M., Brazil, D. P., Burks, D. J., Kushner, J. A., Ye, J., Flint, C. L., et al. (2003). Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J. Neurosci. 23, 7084-7092.
206. Schubert, M., Gautam, D., Surjo, D., Ueki, K., Baudler, S., Schubert, D., et al. (2004). Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. U.S.A. 101, 3100-3105. doi: 10.1073/pnas.0308724101
207. Schulingkamp, R. J., Pagano, T. C., Hung, D., and Raffa, R. B. (2000). Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci. Biobehav. Rev. 24, 855-872. doi: 10.1016/S0149-7634(00)00040-3
208. Scott, A. R., Bennett, T., and Macdonald, I. A. (1987). Diabetes mellitus and thermoregulation. Can. J. Physiol. Pharmacol. 65, 1365-1376. doi: 10.1139/y87-215
209. Selkoe, D. J. (2001). Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J. Alzheimers. Dis. 3, 75-80.
210. Sergeant, N., Bretteville, A., Hamdane, M., Caillet-Boudin, M. L., Grognet, P., Bombois, S., et al. (2008). Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev. Proteomics 5, 207-224. doi: 10.1586/14789450.5.2.207
211. Shalaby, T. H., Yousef, M. K., and Dupre, R. K.(1989). Thermoregulatory responses of diabetic rats. Comp. Biochem. Physiol. A 94,153-157. doi: 10.1016/0300- 9629(89)90800-1
212. Sharma, M., and Gupta, Y. K. (2001). Intracerebroventricular injection of strep- tozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci. 68,1021-1029. doi: 10.1016/S0024-3205(00)01005-5
213. Shepherd, C. E., Thiel, E., McCann, H., Harding, A. J., and Halliday, G. M. (2000). Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies. Arch. Neurol. 57, 817-822. doi: 10.1001/archneur.57.6.817
214. Sims-Robinson, C., Kim, B., Rosko, A., and Feldman, E. L. (2010). How does diabetes accelerate Alzheimer disease pathology? Nat. Rev. Neurol. 6, 551-559. doi: 10.1038/nrneurol.2010.130
215. Singh, B. S., Rajakumar, P. A., Eves, E. M., Rosner, M. R., Wainer, B. H., and Devaskar, S. U. (1997). Insulin gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines. Regul. Pept. 69, 7-14. doi: 10.1016/S0167-0115(96)02120-9
216. Solas, M., Aisa, B., Tordera, R. M., Mugueta, M. C., and Ramirez, M. J. (2013). Stress contributes to the development of central insulin resistance during aging: implications for Alzheimer's disease. Biochim. Biophys. Acta 1832, 2332-2339. doi: 10.1016/j.bbadis.2013.09.013
217. Spranger, J., Kroke, A., Mohlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., et al. (2003). Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52, 812-817. doi: 10.2337/diabetes.52.3.812
218. Taha, C., and Klip, A. (1999). The insulin signaling pathway. J. Membr. Biol. 169, 1-12. doi: 10.1007/PL00005896
219. Takeda, S., Sato, N., Uchio-Yamada, K., Sawada, K., Kunieda, T., Takeuchi, D., et al. (2010). Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc. Natl. Acad. Sci. U.S.A. 107, 7036-7041. doi: 10.1073/pnas.1000 645107
220. Talbot, K., Wang, H. Y., Kazi, H., Han, L. Y., Bakshi, K. P., Stucky, A., et al. (2012). Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122, 1316-1338. doi: 10.1172/JCI59903
221. Terwel, D., Muyllaert, D., Dewachter, I., Borghgraef, P., Croes, S., Devijver, H., et al. (2008). Amyloid activates GSK-3beta to aggravate neuronal tauopa- thy in bigenic mice. Am. J. Pathol. 172, 786-798. doi: 10.2353/ajpath.2008. 070904
222. Thambisetty, M., Jeffrey Metter, E., Yang, A., Dolan, H., Marano, C., Zonderman, A. B., et al. (2013). Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol. 70, 1167-1172. doi: 10.1001/jamaneurol.2013.284
223. Tian, Q., and Wang, J. (2002). Role of serine/threonine protein phosphatase in Alzheimer's disease. Neurosignals 11,262-269. doi: 10.1159/000067425
224. Tirabassi, R. S., Flanagan, J. F., Wu, T., Kislauskis, E. H., Birckbichler, P. J., and Guberski, D. L. (2004). The BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitus. ILAR J. 45, 292-302. doi: 10.1093/ilar.45.3.292
225. Tremblay, M. L., and Giguere, V. (2008). Phosphatases at the heart of FoxO metabolic control. Cell Metab. 7,101-103. doi: 10.1016/j.cmet.2008.01.004
226. Trojanowski, J. Q., and Lee, V. M.(1994). Paired helical filament tau in Alzheimer's disease. The kinase connection. Am. J. Pathol. 144, 449-453.
227. Unger, J. W., Livingston, J. N., and Moss, A. M.(1991). Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. ProgNeurobiol 36, 343-362. doi: 10.1016/0301-0082(91)90015-S
228. Van Der Heide, L. P., Kamal, A., Artola, A., Gispen, W. H., and Ramakers, M. (2005). Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3- kinase-dependent manner. J. Neurochem. 94,1158-1166. doi: 10.1111/j.1471- 4159.2005.03269.x
229. Van Der Jeugd, A., Ahmed, T., Burnouf, S., Belarbi, K., Hamdame, M., Grosjean, M., et al. (2011). Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late- phase long-term depression of synaptic transmission. Neurobiol. Learn. Mem. 296-304. doi: 10.1016/j.nlm.2010.12.005
230. Veerendra Kumar, M. H., and Gupta, Y. K. (2003). Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clin. Exp. Pharmacol. Physiol. 30, 336-342. doi: 10.1046/j.1440-1681.2003.03842.x
231. Vogelsberg-Ragaglia, V., Schuck, T., Trojanowski, J. Q., and Lee, V. M. (2001). PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp. Neurol. 168, 402-412. doi: 10.1006/exnr.2001.7630
232. Wallum, B. J., Taborsky, G. J. Jr., Porte, D. Jr., Figlewicz, D. P., Jacobson, L., Beard, J. C., et al. (1987). Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J. Clin. Endocrinol. Metab. 64, 190-194. doi: 10.1210/jcem-64-1-190
233. Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., and Kirschner, M. W.(1975). A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. U.S.A. 72,1858-1862. doi: 10.1073/pnas.72.5.1858
234. White, M. F. (1997). The insulin signalling system and the IRS proteins. Diabetologia 40 Suppl 2, S2-17. doi: 10.1007/s001250051387
235. White, M. F. (2003). Insulin signaling in health and disease. Science 302, 1710-1711.doi: 10.1126/science.1092952
236. Whittington, R. A., Virag, L., Marcouiller, F., Papon, M. A., El Khoury, N. B., Julien, C, et al. (2011). Propofol directly increases tau phosphorylation. PLoS ONE 6:e16648. doi: 10.1371/journal.pone.0016648
237. Wilcock, G. K., and Esiri, M. M.(1982). Plaques, tangles and dementia. A quantitative study. J. Neurol. Sci. 56, 343-356. doi: 10.1016/0022-510X(82)90155-1
238. Wild, S., Roglic, G., Green, A., Sicree, R., and King, H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053. doi: 10.2337/diacare.27.5.1047
239. Withers, D. J., Burks, D. J., Towery, H. H., Altamuro, S. L., Flint, C. L., and White, M. F.(1999). Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat. Genet. 23, 32-40. doi: 10.1038/12631
240. Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J. M., Previs, S., et al. (1998). Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900-904. doi: 10.1038/36116
241. Xu, W. L., Qiu, C. X., Wahlin, A., Winblad, B., and Fratiglioni, L. (2004). Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 63,1181-1186. doi: 10.1212/01.WNL.0000140291. 86406.D1
242. Yang, Y., Zhang, J., Ma, D., Zhang, M., Hu, S., Shao, S., et al. (2013). Subcutaneous administration of liraglutide ameliorates Alzheimer-associated tau hyperphosphorylation in rats with type 2 diabetes. J. Alzheimers. Dis. 37, 637-648. doi: 10.3233/JAD-130491
243. Yoon, S. Y., Park, J. S., Choi, J. E., Choi, J. M., Lee, W. J., Kim, S. W., et al. (2010). Rosiglitazone reduces tau phosphorylation via JNK inhibition in the hippocampus of rats with type 2 diabetes and tau transfected SH-SY5Y cells. Neurobiol. Dis. 40, 449-455. doi: 10.1016/j.nbd.2010.07.005
244. Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S. M., Iwata, N., Saido, T. C., et al. (2007). Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337-351. doi: 10.1016/j.neuron.2007.01.010
245. Youngren, J. F. (2007). Regulation of insulin receptor function. Cell. Mol. Life Sci.64, 873-891. doi: 10.1007/s00018-007-6359-9
246. Yun, S. W., Gartner, U., Arendt, T., and Hoyer, S. (2000). Increase in vulnerability of middle-aged rat brain to lead by cerebral energy depletion. Brain Res. Bull. 52, 371-378. doi: 10.1016/S0361-9230(00)00274-4
247. Zhao, W., Chen, H., Xu, H., Moore, E., Meiri, N., Quon, M. J., et al. (1999). Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J. Biol. Chem. 274, 34893-34902. doi: 10.1074/jbc.274.49.34893
248. Zhao, W., Wu, X., Xie, H., Ke, Y., and Yung, W. H. (2010). Permissive role of insulin in the expression of long-term potentiation in the hippocampus of immature rats. Neurosignals. 18, 236-245. doi: 10.1159/000324040
249. Zhao, W. Q., and Alkon, D. L. (2001). Role of insulin and insulin receptor in learning and memory. Mol. Cell. Endocrinol. 177, 125-134. doi: 10.1016/S0303- 7207(01)00455-5